BR112022024911A2 - Materiais e métodos para inibir uma infecção viral, incluindo uma infecção por coronavírus - Google Patents

Materiais e métodos para inibir uma infecção viral, incluindo uma infecção por coronavírus

Info

Publication number
BR112022024911A2
BR112022024911A2 BR112022024911A BR112022024911A BR112022024911A2 BR 112022024911 A2 BR112022024911 A2 BR 112022024911A2 BR 112022024911 A BR112022024911 A BR 112022024911A BR 112022024911 A BR112022024911 A BR 112022024911A BR 112022024911 A2 BR112022024911 A2 BR 112022024911A2
Authority
BR
Brazil
Prior art keywords
methods
inhibiting
materials
infection
corona virus
Prior art date
Application number
BR112022024911A
Other languages
English (en)
Portuguese (pt)
Inventor
T Monsul Nicholas
A Berkes Eva
T Boehm Frederick
Liao Yu-Hsien
Original Assignee
Quorum Innovations Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quorum Innovations Llc filed Critical Quorum Innovations Llc
Publication of BR112022024911A2 publication Critical patent/BR112022024911A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112022024911A 2020-06-06 2021-06-07 Materiais e métodos para inibir uma infecção viral, incluindo uma infecção por coronavírus BR112022024911A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063035733P 2020-06-06 2020-06-06
PCT/US2021/036104 WO2021248111A1 (en) 2020-06-06 2021-06-07 Materials and methods for inhibiting a viral infection, including a coronavirus infection

Publications (1)

Publication Number Publication Date
BR112022024911A2 true BR112022024911A2 (pt) 2022-12-27

Family

ID=78831585

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022024911A BR112022024911A2 (pt) 2020-06-06 2021-06-07 Materiais e métodos para inibir uma infecção viral, incluindo uma infecção por coronavírus

Country Status (11)

Country Link
US (2) US11826390B2 (https=)
EP (1) EP4161558A4 (https=)
JP (1) JP2023529152A (https=)
KR (1) KR20230025853A (https=)
CN (1) CN116133669A (https=)
AU (1) AU2021286002A1 (https=)
BR (1) BR112022024911A2 (https=)
CA (1) CA3180737A1 (https=)
IL (1) IL298401A (https=)
MX (1) MX2022015439A (https=)
WO (1) WO2021248111A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022006163A (es) * 2019-11-26 2022-06-17 Quorum Innovations Llc Nuevas composiciones de barrera protectora y usos de las mismas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
WO2007040446A1 (en) 2005-10-06 2007-04-12 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
BRPI0822997A2 (pt) * 2008-09-04 2015-06-23 Om Pharma Extratos imunomoduladores de bactérias lactobacillus e métodos para fabricação e uso dos mesmos
KR101378608B1 (ko) * 2011-04-13 2014-03-27 씨제이제일제당 (주) 바이러스 감염 억제 활성을 갖는 신규 분리한 락토바실러스 퍼멘텀 균주
DK3324986T3 (da) * 2015-07-20 2022-01-31 Quorum Innovations Llc Materialer og fremgangsmåder til forbedring af immunreaktioner og hud- og/eller slimhindebarrierefunktion
CA3176797A1 (en) * 2020-05-06 2021-11-11 Nicholas T. Monsul Novel protein, and therapeutic and cosmetic uses thereof

Also Published As

Publication number Publication date
US20230136276A1 (en) 2023-05-04
AU2021286002A1 (en) 2023-01-19
JP2023529152A (ja) 2023-07-07
EP4161558A1 (en) 2023-04-12
US20240075083A1 (en) 2024-03-07
KR20230025853A (ko) 2023-02-23
WO2021248111A1 (en) 2021-12-09
EP4161558A4 (en) 2024-06-19
IL298401A (en) 2023-01-01
CN116133669A (zh) 2023-05-16
MX2022015439A (es) 2023-03-22
CA3180737A1 (en) 2021-12-09
WO2021248111A9 (en) 2022-12-22
US11826390B2 (en) 2023-11-28

Similar Documents

Publication Publication Date Title
BRPI0616960B8 (pt) uso de lactobacilo para o tratamento de infecções virais
MX2019010143A (es) Bifidobacterium longum capaz de modular beneficiosamente la respuesta inmune contra una infeccion respiratoria por virus.
BR112022018819A2 (pt) Vacinas contra coronavírus e métodos de uso
PE20230767A1 (es) Redireccion del tropismo de las capsides de aav
ECSP21042554A (es) Proteínas f de prefusión del vrs estabilizadas
MX2023000411A (es) Vacuna combinada de sars-cov-2 e influenza.
BR112018014654A2 (pt) cepa inovadora de bactérias probióticas e composições e usos da mesma
BR112021015751A2 (pt) Vetores de terapia genética para tratamento da doença de danon
EA202090769A1 (ru) Пищевая, косметическая и фармацевтическая композиция с иммуномодулирующим и протективным антивирусным эффектом
BR112018016359A2 (pt) biopesticidas para doença de requeima da batata
MX2020007777A (es) Vacunas contra virus de la gripe y usos de las mismas.
BR112022025134A2 (pt) 5-amino-2,3-dihidro-1,4-ftalazinadiona, composição, combinação, e, método de tratamento de uma infecção coronaviral
BR112018075440A2 (pt) composições e métodos para prevenir e tratar a infecção por zika vírus
WO2006088481A3 (en) Genetically engineered equine influenza virus and uses thereof
BR112022016891A2 (pt) Vacina contra a infecção por vírus da peste suína africana
CL2024000062A1 (es) Composición farmacéutica de virus no encapsulado
MX351380B (es) Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino.
BR112023000233A2 (pt) Cepa da espécie lacticaseibacillus rhamnosus, composições da mesma e uso da mesma no tratamento de infecções genitourinárias
WO2017199022A3 (en) Lactobacillus rhamnosus lysate compositions and uses thereof
BR112022024911A2 (pt) Materiais e métodos para inibir uma infecção viral, incluindo uma infecção por coronavírus
SA520420261B1 (ar) تركيبات إرنوماب واستخداماتها
BR112023026164A2 (pt) Bacteriófagos contra enterococci resistentes à vancomicina
Ellerhoff et al. Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
BR112022007253A2 (pt) Vacinas contra o vírus influenza e usos das mesmas
BR112022005345A2 (pt) Composições imunogênicas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.